Farid Mohamed, Youssef Tamer, Mahdy Tarek, Omar Waleed, Moneim Hesham Abdul, El Nakeeb Ayman, Youssef Mohamed
Mansoura Faculty of Medicine, Mansoura, Egypt.
Int J Colorectal Dis. 2009 Mar;24(3):327-34. doi: 10.1007/s00384-008-0609-7. Epub 2008 Nov 29.
The objective of this study was to compare the results of partial division of puborectalis (PDPR) versus local botulinum toxin type A (BTX-A) injection in treating patients with anismus.
This prospective randomized study included 30 male patients suffering from anismus. Diagnosis was made by clinical examination, barium enema, colonoscopy, colonic transit time, anorectal manometry, balloon expulsion test, defecography, and electromyography. Patients were randomized into: group I which included 15 patients who were injected with BTX-A and group II which included 15 patients who underwent bilateral PDPR. Follow-up was conducted for about 1 year. Improvement was considered when patients returned to their normal habits.
BTX-A injection achieved initial success in 13 patients (86.7%). However, long-term success persisted only in six patients (40%). This was in contrast to PDPR which achieved initial success in all patients (100%) with a long-term success in ten patients (66.6%). Recurrence was observed in seven patients (53.8%) and five patients (33.4%) following BTX-A injection and PDPR, respectively. Minor degrees of incontinence were confronted in two patients (13.3%) following PDPR.
BTX-A injection seems to be successful for temporary treatment of anismus.
本研究的目的是比较耻骨直肠肌部分离断术(PDPR)与局部注射A型肉毒杆菌毒素(BTX-A)治疗排便障碍型便秘患者的效果。
这项前瞻性随机研究纳入了30例排便障碍型便秘男性患者。通过临床检查、钡灌肠、结肠镜检查、结肠传输时间、肛门直肠测压、气囊排出试验、排粪造影和肌电图进行诊断。患者被随机分为:I组,包括15例接受BTX-A注射的患者;II组,包括15例接受双侧PDPR的患者。随访约1年。当患者恢复正常排便习惯时视为病情改善。
BTX-A注射使13例患者(86.7%)取得初步成功。然而,长期成功仅持续在6例患者(40%)中。这与PDPR形成对比,PDPR使所有患者(100%)取得初步成功,10例患者(66.6%)获得长期成功。BTX-A注射和PDPR后分别有7例患者(53.8%)和5例患者(33.4%)出现复发。PDPR后有2例患者(13.3%)出现轻度失禁。
BTX-A注射似乎对排便障碍型便秘的临时治疗有效。